ReviewFrontiers in bioengineering and biotechnology2025
Emergent biotechnology applications in urology: a mini review.
Review in Frontiers in bioengineering and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Animal models of spinal cord injury in neuro-urological research.Nature reviews. Urology · 2026Review
- Recent Technological Advances in Monitoring and Neuromodulation of Non-Malignant and Neurogenic Bladder Conditions.Advanced healthcare materials · 2026Review
- Design of Soft, Stretchable Bladder-Integrated Scaffolds for Advanced Bioelectronic Implants.Advanced materials technologies · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Technological advances have significantly impacted the field of urology, providing innovative solutions for diagnosis, treatment, and management of various urological disorders and diseases. This article highlights four groundbreaking technologies: whole-cell biosensors, optogenetic interventions for neuromodulation, bioengineered urinary bladder, and 3D bioprinting. Each technology plays a crucial role in enhancing patient care and improving clinical outcomes in urology. Advances in these fields underscore a shift towards precision diagnostics, personalized treatments, and enhanced regenerative strategies, ultimately aiming to enhance patient outcomes and address unmet clinical needs in urological diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.